Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James M Brophy

Showing results (31-40 of 242) with videos related to

Pageof 25
Sort By:
JACC. Cardiovascular Interventions|August 8, 2025
A Protective Effect of Smoking on Repeat Revascularization: Another Example of Collider Stratification BiasJames M Brophy
BMJ (Clinical Research Ed.)|July 15, 2020
US purchases world stocks of remdesivir: why the rest of the world should be glad to be at the back of the queueJames M Brophy
The Canadian Journal of Cardiology|March 29, 2021
Bayesian Analyses of Cardiovascular Trials-Bringing Added Value to the TableJames M Brophy
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|February 28, 2007
Pravastatin and cancer: an unproven associationJames M Brophy
Nature Clinical Practice. Cardiovascular Medicine|October 26, 2006
Vascular events with selective COX2 inhibitors and NSAIDs: analyzing the risksJames M Brophy
The Canadian Journal of Cardiology|June 17, 2020
The Dollars and Sense of Transcatheter Aortic Valve Replacement: An Example of the Benefit of Avoiding Stenoses in Health Care Services ResearchJames M Brophy
JAMA Internal Medicine|June 2, 2020
Bayesian Interpretation of the EXCEL Trial and Other Randomized Clinical Trials of Left Main Coronary Artery RevascularizationJames M Brophy
Annals of Internal Medicine|August 1, 2022
In HF, SGLT2 inhibitors reduce HF hospitalizations at up to 2 yJames M Brophy
Indian Journal of Medical Ethics|September 9, 2016
Vioxx redux - or how I learned to worry about industry-sponsored clinical trialsJames M Brophy
Expert Opinion on Drug Safety|November 1, 2005
Celecoxib and cardiovascular risksJames M Brophy
Pageof 25

Showing results (31-40 of 242) with videos related to

Sort By:
Pageof 25
JACC. Cardiovascular Interventions|August 8, 2025
A Protective Effect of Smoking on Repeat Revascularization: Another Example of Collider Stratification BiasJames M Brophy
BMJ (Clinical Research Ed.)|July 15, 2020
US purchases world stocks of remdesivir: why the rest of the world should be glad to be at the back of the queueJames M Brophy
The Canadian Journal of Cardiology|March 29, 2021
Bayesian Analyses of Cardiovascular Trials-Bringing Added Value to the TableJames M Brophy
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|February 28, 2007
Pravastatin and cancer: an unproven associationJames M Brophy
Nature Clinical Practice. Cardiovascular Medicine|October 26, 2006
Vascular events with selective COX2 inhibitors and NSAIDs: analyzing the risksJames M Brophy
The Canadian Journal of Cardiology|June 17, 2020
The Dollars and Sense of Transcatheter Aortic Valve Replacement: An Example of the Benefit of Avoiding Stenoses in Health Care Services ResearchJames M Brophy
JAMA Internal Medicine|June 2, 2020
Bayesian Interpretation of the EXCEL Trial and Other Randomized Clinical Trials of Left Main Coronary Artery RevascularizationJames M Brophy
Annals of Internal Medicine|August 1, 2022
In HF, SGLT2 inhibitors reduce HF hospitalizations at up to 2 yJames M Brophy
Indian Journal of Medical Ethics|September 9, 2016
Vioxx redux - or how I learned to worry about industry-sponsored clinical trialsJames M Brophy
Expert Opinion on Drug Safety|November 1, 2005
Celecoxib and cardiovascular risksJames M Brophy
Pageof 25